The Evaluation of the Seroprevalence of HBV, HCV and HIV Infections and the Assessment of Antibody Response to Hepatitis B Vaccination in Hemodialysis Patients
PDF
Cite
Share
Request
Research Article
P: 140-143
December 2013

The Evaluation of the Seroprevalence of HBV, HCV and HIV Infections and the Assessment of Antibody Response to Hepatitis B Vaccination in Hemodialysis Patients

Viral Hepat J 2013;19(3):140-143
1.
2.
3.
4.
5. Diyarbakir Egitim Ve Arastirma Hastanesi, Nefroloji Klinigi, Diyarbakir, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

ABSTRACT

Objective:

In this study; we aimed to determine the the effectiveness of infection control measures in patients undergoing hemodialysis for chronic renal failure by analyzing the HBsAg, anti-HBs, anti-HCV and anti-HIV serologic indicators retrospectively.

Materials and Methods:

HBsAg, anti-HBs, anti-HCV and anti-HIV parameters of 96 patients receiving hemodialysis treatment in 2012 were analysed with the ADVIA Centaur XP Immunoassay System by CLIA method.

Results:

In this study; there was no HBsAg and anti-HIV positive patients. All the patients were regularly and fully vaccinated for hepatitis B but 10 patients (10.4%) had anti-HBs antibody level under 10 mIU/mL. 4 patients (4.1%) were positive for anti-HCV. Statistically significant difference was detected in anti-HCV positivity for hemodialysis duration, gender, history of dental treatment and the presence of hepatitis in the family.

Conclusion:

In conclusion; appropriate infection control measures in hemodialysis patients, immunization and education of patients and health care workers can reduce the possibility of transmission of infectious agents.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House